Market Research Industry Today
Electrophysiology Market: Analysis and In-depth study on market Size Trends, Emerging Growth Factors and Regional Forecast to 2022
Catheter ablation is highly preferred device due to its minimal invasive nature and is designated as ‐gold standard‐ modality for treating atrial fibrillation. The growing adoption of this device by the physicians or electrophysiologists has catered double digit growth in the study period.
Published 19 April 2019
Electrophysiology Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $8,271 million by 2022, registering a CAGR of 13.4% during the period 2016-2022. Electrophysiology (EP) ablation catheters is expected to dominate the global electrophysiology market throughout the forecast period. North America accounted more than one-third share of the global electrophysiology market in 2015.
The market is driven by growth in incidence of atrial fibrillation (one of the most common heart rhythm disorder or cardiac arrhythmia), growth in baby boomer generation with high-risk of targeted diseases, and increase in adoption of EP catheter ablation.
Get sample copy of this report @
https://www.alliedmarketresearch.com/request-sample/452
_1555679186.jpg)
Rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, bidirectional duodecapolar diagnostic catheter, remote steering systems, and irrigated-tip RF catheters), and growth in EP labs further drives the market growth. However, stringent government regulations, high cost of the treatment of complex arrhythmias, preference to pharmaceutical interventions (drugs) over, and dearth of skilled & experienced electrophysiologists restrain the market growth.
Key Findings of the Electrophysiology Market:
• In 2015, EP ablation catheter was the leading product type, and is projected to grow at a high CAGR of 14.4%.
• Cryoablation EP catheters is expected to grow at a remarkable CAGR of 15.1%.
• Irrigated-tip RF ablation catheters is projected to grow at a high CAGR of 14.6%.
• U.S. was the highest market shareholder with over 80% in the North American region in 2015.
• Japan is the major shareholder, accounting for around half of the Asia-Pacific electrophysiology market.
• North America is expected to dominate the EP market followed Europe, during the analysis period.
Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/452
Atrial fibrillation (AF) indication segment is expected to maintain its lead in the overall electrophysiology market due to its high incidence rate, especially in the developed economies. Although, the AF cases are prevalent in the developing economies, the low awareness, less initiative for preventive care, and unmet medical needs at economical cost has restricted the market growth.
Top Key Players :
• St. Jude Medical Inc.
• Biosense Webster Inc. (A Johnson & Johnson Company)
• Boston Scientific Corporation
• Medtronic Inc.
• GE Healthcare (Division of General Electric Co.)
• Siemens AG
• Medtronic plc
• Philips Healthcare
Get Access to Full summary of this report @
https://www.alliedmarketresearch.com/electrophysiology-devices-market
The market is driven by growth in incidence of atrial fibrillation (one of the most common heart rhythm disorder or cardiac arrhythmia), growth in baby boomer generation with high-risk of targeted diseases, and increase in adoption of EP catheter ablation.
Get sample copy of this report @
https://www.alliedmarketresearch.com/request-sample/452
Rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, bidirectional duodecapolar diagnostic catheter, remote steering systems, and irrigated-tip RF catheters), and growth in EP labs further drives the market growth. However, stringent government regulations, high cost of the treatment of complex arrhythmias, preference to pharmaceutical interventions (drugs) over, and dearth of skilled & experienced electrophysiologists restrain the market growth.
Key Findings of the Electrophysiology Market:
• In 2015, EP ablation catheter was the leading product type, and is projected to grow at a high CAGR of 14.4%.
• Cryoablation EP catheters is expected to grow at a remarkable CAGR of 15.1%.
• Irrigated-tip RF ablation catheters is projected to grow at a high CAGR of 14.6%.
• U.S. was the highest market shareholder with over 80% in the North American region in 2015.
• Japan is the major shareholder, accounting for around half of the Asia-Pacific electrophysiology market.
• North America is expected to dominate the EP market followed Europe, during the analysis period.
Send Enquiry on this report @
https://www.alliedmarketresearch.com/purchase-enquiry/452
Atrial fibrillation (AF) indication segment is expected to maintain its lead in the overall electrophysiology market due to its high incidence rate, especially in the developed economies. Although, the AF cases are prevalent in the developing economies, the low awareness, less initiative for preventive care, and unmet medical needs at economical cost has restricted the market growth.
Top Key Players :
• St. Jude Medical Inc.
• Biosense Webster Inc. (A Johnson & Johnson Company)
• Boston Scientific Corporation
• Medtronic Inc.
• GE Healthcare (Division of General Electric Co.)
• Siemens AG
• Medtronic plc
• Philips Healthcare
Get Access to Full summary of this report @
https://www.alliedmarketresearch.com/electrophysiology-devices-market
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
